10 hrs ago
Merck second-quarter profit more than doubles, tops forecast
A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.
11 hrs ago
Merck Announces Second-Quarter 2014 Financial Results
Non-GAAP earnings per share for the second quarter of $0.85 exclude acquisition- and divestiture-related costs, restructuring costs and certain other items.
Thu Jul 24, 2014
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in...
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized Phase 3 trial.
Mon Jul 21, 2014
Effects of Lowering LDL Cholesterol on Progression of Kidney Disease.
Lowering LDL cholesterol reduces the risk of developing atherosclerotic events in CKD, but the effects of such treatment on progression of kidney disease remain uncertain.
Wed Jul 16, 2014
New Findings from Cleveland Clinic Update Understanding of...
Statin intolerance, which is predominantly due to muscle-related side effects, is reported in up to 10% to 20% of patients."
Tue Jul 15, 2014
Impact of Drug Policy on Regional Trends in Ezetimibe Use [Original Articles]
From the Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA ; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA ; Department of Medicine, Section of Cardiovascular Medicine and Center for Outcomes Research and Evaluation, Yale New Haven Hospital , Yale ... (more)
Sun Jul 13, 2014
Which diet is the right diet?
Dear Dr. Roach: I am taking Zetia and niacin for extremely high cholesterol and triglycerides.
Thu Jul 10, 2014
Why are doctors still prescribing Zetia?
A health research company just released a list of the 100 top drugs in America according to sales.
Mon Jul 07, 2014
Merck Says It Regrets Strong-Arming Italian Researcher
Merck says that it "regrets" using legal threats to push a leading Italian researcher to muffle his public critiques of one of the company's cholesterol drugs.
Sun Jul 06, 2014
Merck Uses Legal Threats To Stifle Negative Advice About Zetia And Vytorin In Italy
In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug.